Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer Meeting Abstract


Authors: Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; Regazzi, A. M.; Jihad, M.; Bajorin, D. F.; Balar, A. V.; Mortazavi, A.; Merghoub, T.; Iyer, G.; Rosenberg, J. E.; Greenbaum, B.; Funt, S. A.
Abstract Title: Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680301404
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.4584
Notes: Meeting Abstract: 4584 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    660 Bajorin
  2. Taha Merghoub
    364 Merghoub
  3. Gopakumar Vasudeva Iyer
    348 Iyer
  4. Ashley Regazzi
    92 Regazzi
  5. Jonathan Eric Rosenberg
    517 Rosenberg
  6. Samuel Aaron Funt
    139 Funt
  7. Min Yuen   Teo
    105 Teo
  8. Marwah Jihad
    9 Jihad
  9. David Henry Aggen
    59 Aggen
  10. Karissa A. Whiting
    49 Whiting
  11. Jayon Lihm
    10 Lihm
  12. Hao Li
    3 Li